Skip to main content

Encephalitis clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for
  • ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

    open to eligible people ages 12 years and up

    Determine the difference in the modified Rankin score at 16 weeks in participants with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis treated with "first-line" immunomodulatory therapies provided as standard-of-care, and either inebilizumab (investigational agent) or placebo.

    at UC Davis UC Irvine

  • CoMind Early Feasibility Study

    open to eligible people ages 18 years and up

    The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pressure or ICP). Monitoring and managing ICP is an important part of care for patients with conditions such as Traumatic Brain Injury (TBI). However, the current way of measuring ICP requires surgery to drill a hole into the skull, and therefore can introduce additional risks such as infections and pain. Recent research has shown it may be possible to measure ICP without needing surgery. This technology is in development, but large amounts of data is required to build these new devices. Through collecting a large database of information from patients who have both the routine surgical device and the research device applied to their head, the research team will work to develop and test an effective and potentially safer way of monitoring patient ICP.

    at UC Davis

Our lead scientists for Encephalitis research studies include .

Last updated: